Comparing Two Surveillance Approaches for People Who Have Received Treatment for HPV-associated Head and Neck Cancer and Show No Signs of Disease

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Squamous Cell Carcinoma
Interventions
OTHER

Standard surveillance

Participant coming to the clinic for in-person follow-up visits and having routine endoscopy and cancer imaging procedures as needed

OTHER

Telemedicine surveillance (tele-surveillance)

The tele-surveillance visit occurs annually after completion of therapy and consists of a phone call with or without video conferencing between the patient and the treatment team (physician, nurse, and/ or nurse practitioner). The use of video conferencing is strongly encouraged. Clinic visits, endoscopies, and imaging studies can be performed at the discretion of the treatment team for concerning patient symptoms.

OTHER

Questionnaires

EORTC QLQ-C30 and EORTC QLQ-HN43 at 12 and 24 months, FACE-Questionnaire Module, Telehealth Usability Questionnaire, Telehealth Usability Questionnaire, Functional Assessment of Chronic Illness Therapy - Treatment Satisfaction -Patient Satisfaction inventory

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER